* IRadimed Corp IRMD.OQ reported quarterly adjusted earnings
of 23 cents per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was
for earnings of 17 cents per share.
* Revenue rose 41.7% to $10.91 million from a year ago;
analysts expected $10.40 million.
* IRadimed Corp's reported EPS for the quarter was 20 cents.
* The mean earnings estimate of analysts had risen by
about 30.8% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* IRadimed Corp shares had risen by 7.8% this quarter and
gained 58.8% so far this year.
* The company reported quarterly net income of $2.58 million.
* Wall Street's median 12-month price target for IRadimed Corp
is $38.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated October 29 at 01:31 p.m.
All figures in US dollars unless otherwise stated